A new study led by researchers at the American Cancer Society (ACS) finds four in 10 cancer cases and about one-half of all cancer deaths in adults 30 years old and older in the United States (or 713,340 cancer cases and 262,120 cancer deaths in 2019) could be attributed to modifiable risk factors, including cigarette smoking, excess body weight, alcohol consumption, physical inactivity, diet, and infections. Cigarette smoking was by far the leading risk factor, contributing to nearly 20% of all cancer cases and 30% of all cancer deaths. The findings are published today in the journal CA: A Cancer Journal for Clinicians.

New study finds 40-percent of cancer cases and almost half of all deaths in the US linked to modifiable risk factors

The US Food and Drug Administration has approved Guardant Health’s Shield blood test for colorectal cancer (CRC) screening in adults aged 45 and older at average risk for the disease. The approval, announced on July 29, 2024, is based on results from the ECLIPSE study, which enrolled more than 20,000 average-risk patients. The Shield test is the first blood test to be approved by the FDA as a primary screening option for CRC and the first to meet the requirements for Medicare coverage.

FDA Approves New Blood Test To Screen For Colon Cancer

LiveScience

An early screening test for endometrial cancer may be missing the disease in many Black patients.

Black patients may be missed on common cancer screening, study suggests

Diverticulitis and colon cancer share some similar symptoms, risk factors, and diagnostic tests. Research suggests there may be a link between the two conditions, and having diverticulitis may increase the risk of colon cancer. Diverticulitis and colon cancer both involve the colon, which forms part of the large intestine. Colon...

Is there a connection between diverticulitis and colon cancer?

Mediaite

After meeting with Israeli Prime Minister Benjamin Netanyahu, Trump claimed that Jewish voters who support Kamala Harris "should have their head examined."
The post Trump Says ‘Any Jewish Person’ Who Supports Kamala Harris ‘Should Have Their Head Examined’ first appeared on Mediaite.

Trump Says ‘Any Jewish Person’ Who Supports Kamala Harris ‘Should Have Their Head Examined’

Dealing with constipation? Chances are you’ve been “backed up” at some point in your life. The reality is that digestive issues like constipation and bloating are uncomfortable, and they can really put a damper on your day. Fortunately, herbs and spices have been shown to support digestive...

The #1 Spice to Help You Poop, According to Dietitians

Inflation has caught up with McDonald’s, and budget-conscious Americans are looking elsewhere for their fast-food fix. But McDonald’s believes it has a solution: Value meals.

Americans keep turning their backs on McDonald’s

New York City, NY

Writers represent independent, third-party users who have joined our contributor program and self-verified their accounts. Writers are expected, like all users, to adhere to our Community Standards.

writer

Cheryl E Preston

Yesterday was the third time this year that an ad stating Chelsea Clinton lives in a beautiful Virginia home popped up on my laptop. My computer did not warn me this was a dangerous site, so this time, I clicked on the link.

Chelsea Clinton is rumored to be living in Virginia but probably still in NYC

A group of 45 American doctors and nurses describe bloodshed in Gaza in an open letter to the White House, and demand immediate ceasefire.

‘We cannot remain silent about what we saw.’ US doctors who volunteered in Gaza demand ceasefire in letter to White House

Reuters

(Reuters) - Guardant Health said its blood test to detect cancer that starts in the colon or rectum got an approval from the U.S. Food and Drug Administration, with the test moving closer toward gaining coverage under the country's Medicare insurance program.

Guardant's blood-based cancer test moves closer to Medicare coverage with FDA approval

New York Post

Guardant Health said its blood test to detect a cancer that starts in the colon or rectum got an approval from the U.S. Food and Drug Administration, sending the company’s shares up 16% in premarket trading on Monday.

The test, known as Shield, has been available in the U.S. as a laboratory-developed test (LDT) since 2022 and is available for a self-pay price of $895.

LDTs are designed, manufactured and used within a single laboratory, but FDA’s approval takes Shield a step closer to becoming the first blood test for colorectal cancer (CRC) screening that is eligible for Medicare insurance coverage for...

FDA approves blood-based cancer test in medical breakthrough

A landmark study revealed that women with severe endometriosis are ten times more likely to get ovarian cancer, compared to women who do not suffer from the disease. The study was conducted by researchers at Huntsman Cancer Institute at the University of Utah, the Spencer Fox Eccles School of Medicine, and Boston University Chobanian & Avedisian School of Medicine.

Are Women With Severe Endometriosis More Likely To Get Cancer ?

Donald Trump has agreed to sit for a victim interview with the FBI, which is investigating this month’s attempted assassination, an agency official said Monday.

FBI to ask for Trump’s ‘perspective’ in shooting probe witness interview

Although colorectal cancer may not be entirely preventable, a person can take certain steps to reduce their risk of developing it. These include screenings, avoiding cigarettes and alcohol, and more. Colorectal cancer is a form of cancer that begins in a person’s colon or rectum. The colon is also...

Is it possible to prevent colorectal cancer?

Woman's World

Who knew? Discomfort in your groin is a hallmark symptom of hip osteoarthritis

The Top 4 Causes of Hip Joint Pain and the Sneaky Spot You May Notice Symptoms

The Associated Press

PALO ALTO, Calif.--(BUSINESS WIRE)--Jul 29, 2024-- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the U.S. Food and Drug Administration (FDA) has approved the company’s Shield™ blood test for colorectal cancer (CRC) screening in adults age 45 and older who are at average risk for the disease. It is the first blood test to be approved by the FDA as a primary screening option for CRC, meaning healthcare providers can offer Shield in a manner similar to all other non-invasive methods recommended in screening guidelines. Shield is also the first blood test for CRC screening that meets the requirements for Medicare coverage. 1 This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240725240089/en/ Shield is a blood test from Guardant Health for colorectal cancer screening in average-risk individuals 45 and older. (Photo: Business Wire)

Guardant Health’s Shield™ Blood Test Approved by FDA as a Primary Screening Option, Clearing Path for Medicare Reimbursement and a New Era of Colorectal Cancer Screening

Everyday Health

The new topical treatment works quickly and has fewer side effects than other treatments for this common type of eczema, and it can be used for any length of time.

FDA Approves Steroid-Free Cream for Atopic Dermatitis

Summary: A new study reveals that an at-home colorectal cancer screening test, FIT, can reduce the risk of colorectal cancer death by 33%, showing similar effectiveness across various racial groups. Takeaways:. Significant Mortality Reduction: The study found that at-home FIT screening reduces colorectal cancer mortality by 33% and is as...

At-Home Colon Cancer Screening Test Reduces Risk of Colorectal Cancer Death

CNN senior data reporter Harry Enten breaks down the latest polling data that shows how Vice President Kamala Harris has multiple paths to victory over former President Donald Trump.

Polling shows Harris has multiple paths to victory

Sangamon County, IL

Before he killed a mother in her home, former sheriff’s deputy Sean Grayson had a history of problems in the Army and another sheriff’s agency, records show.

Deputy who killed Sonya Massey was removed from the Army, had DUIs and needed ‘high stress decision’ classes, records show

NewsBreak

FDA approves blood test for colorectal cancer screening among average-risk adults in the US

The US Food and Drug Administration has approved a blood test to be used for colorectal cancer screening among average-risk adults 45 and...

FDA approves blood test for colorectal cancer screening among average-risk adults in the US

Comments / 0